PortfoliosLab logoPortfoliosLab logo
ISIN
US26622P1075
CUSIP
26622P107
IPO Date
Jun 24, 2021

Highlights

Market Cap
$3.91B
Enterprise Value
$3.71B
EPS (TTM)
$0.98
PE Ratio
20.38
PEG Ratio
1.74
Total Revenue (TTM)
$644.86M
Gross Profit (TTM)
$574.54M
EBITDA (TTM)
$245.76M
Year Range
$17.15 - $76.51
Target Price
$41.86
ROA (TTM)
17.45%
ROE (TTM)
20.62%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

DOCS Performance Chart

Doximity, Inc. (DOCS) is down 54.7% since the beginning of the year. At $20 per share, DOCS is trading 73.8% below its 52-week high of $77.


Loading charts...

S&P 500 Index

Returns By Period

Doximity, Inc. (DOCS) has returned -54.67% so far this year and -65.01% over the past 12 months.


Doximity, Inc.

1D
-1.91%
1M
0.65%
YTD
-54.67%
6M
-55.38%
1Y
-65.01%
3Y*
-14.45%
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DOCS Monthly Returns History

Based on dividend-adjusted daily data since Jun 24, 2021, DOCS's average daily return is +0.04%, while the average monthly return is +0.28%. At this rate, an investment would double in approximately 20.7 years.

Historically, 43% of months were positive and 57% were negative. The best month was Aug 2021 with a return of +48.6%, while the worst month was Feb 2026 at -34.5%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.

On a daily basis, DOCS closed higher 50% of trading days. The best single day was Aug 9, 2024 with a return of +38.7%, while the worst single day was May 14, 2026 at -23.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-15.38%-34.53%-5.01%4.89%-12.44%-6.21%-54.67%
202510.69%19.29%-17.69%-1.98%-8.42%17.76%-4.22%15.64%7.67%-9.77%-22.06%-13.92%-17.06%
2024-3.89%4.75%-4.68%-9.74%14.16%0.87%0.11%31.36%18.46%-4.20%26.98%0.74%90.41%
20235.10%-4.65%-3.72%13.50%-16.54%10.92%5.03%-33.28%-10.99%-3.72%13.80%20.60%-16.45%
2022-9.10%34.63%-15.09%-23.46%-12.24%-0.49%21.54%-21.57%-8.95%-12.41%28.41%-1.27%-33.05%
202141.37%6.36%48.63%-12.28%-13.90%-2.63%-25.90%21.76%

Benchmark Metrics

Doximity, Inc. has an annualized alpha of -9.00%, beta of 1.43, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since June 24, 2021.

  • This stock participated in 179.00% of S&P 500 Index downside but only 90.55% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.12 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-9.00%
Beta
1.43
0.12
Upside Capture
90.55%
Downside Capture
179.00%

Return for Risk

Risk / Return Rank

DOCS ranks 5 for risk / return — in the bottom 5% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


DOCS Risk / Return Rank: 55
Overall Rank
DOCS Sharpe Ratio Rank: 22
Sharpe Ratio Rank
DOCS Sortino Ratio Rank: 33
Sortino Ratio Rank
DOCS Omega Ratio Rank: 22
Omega Ratio Rank
DOCS Calmar Ratio Rank: 99
Calmar Ratio Rank
DOCS Martin Ratio Rank: 88
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Doximity, Inc. (DOCS) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DOCSBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-3.24

Sortino ratioReturn per unit of downside risk

-4.73

Omega ratioGain probability vs. loss probability

0.72

1.37

-0.65

Calmar ratioReturn relative to maximum drawdown

-0.86

2.78

-3.64

Martin ratioReturn relative to average drawdown

-1.39

12.44

-13.83

Dividends

Dividend History


Doximity, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Doximity, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Doximity, Inc. was 82.35%, occurring on May 14, 2026. The portfolio has not yet recovered.

The current Doximity, Inc. drawdown is 80.33%.


Related event

Drawdown

Fall

Recovery

Underwater

2026 bear market2026
-82.35%May 2026
4y 8mo
4y 9moSep 2021 - now
2021 bear market2021
-21.26%Aug 2021
10d5d
15dJul 2021 - Aug 2021
2021 correction2021
-19.76%Jul 2021
7d16d
23dJun 2021 - Jul 2021
2021 correction2021
-12.81%Aug 2021
0s7d
7dAug 2021 - Sep 2021
2021 pullback2021
-7.11%Aug 2021
2d4d
6dAug 2021 - Aug 2021

Drawdown Indicators


DOCSBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-82.35%

-56.78%

-25.57%

Max Drawdown (1Y)

Largest decline over 1 year

-76.03%

-9.10%

-66.93%

Max Drawdown (3Y)

Largest decline over 3 years

-78.34%

-18.90%

-59.44%

Max Drawdown (5Y)

Largest decline over 5 years

-82.35%

-25.43%

-56.92%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-80.33%

-1.80%

-78.53%

Average Drawdown

Average peak-to-trough decline

-57.27%

-10.71%

-46.56%

Ulcer Index

Depth and duration of drawdowns from previous peaks

46.63%

2.03%

+44.60%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Doximity, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Doximity, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for DOCS, comparing it with other companies in the Health Information Services industry. Currently, DOCS has a P/E ratio of 20.4. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for DOCS compared to other companies in the Health Information Services industry. DOCS currently has a PEG ratio of 1.7. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for DOCS relative to other companies in the Health Information Services industry. Currently, DOCS has a P/S ratio of 6.2. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for DOCS in comparison with other companies in the Health Information Services industry. Currently, DOCS has a P/B value of 4.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with DOCS

Add Doximity, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with DOCS